AI Article Synopsis
- - The text discusses the importance of lifestyle medicine in treating diabetes and highlights the difficulty of finding a successful model for creating a Lifestyle Medicine Program (LMP).
- - Lifedoc Health (LDH) is presented as a successful example, utilizing a multidisciplinary team approach to enhance diabetes care, addressing sustainability challenges, and focusing on patient engagement and equitable healthcare.
- - While there are many strategic plans for LMPs in diabetes care in literature, there is a gap in practical implementation and performance metrics; the LDH experience serves as a useful starting point for healthcare professionals seeking to take action.
Article Abstract
Introduction: The relevance of lifestyle medicine in diabetes treatment is now incorporated in clinical practice guidelines but finding an exemplar for the creation of a Lifestyle Medicine Program (LMP) is a difficult task.
Aim: To use Lifedoc Health (LDH) as a LMP exemplar by describing their multidisciplinary team (MDT) approach to diabetes care along with tactics to address sustainability challenges.
Results: The LDH model facilitates early activation of patients with diabetes and other cardiometabolic risk factors, MDT approaches, and protocols/policies that are able to overcome barriers to equitable healthcare in the community. Specific programmatic targets are clinical outcomes, effective dissemination, economic viability, and sustainability. Infrastructure centers on patient-driven problem-based visits, shared medical appointments, telemedicine, and patient tracking. Further discussions on program conceptualization and operationalization are provided.
Conclusion: Even though strategic plans for LMPs that specialize in diabetes care are well represented in the literature, implementation protocols, and performance metrics are lacking. The LDH experience provides a starting point for those healthcare professionals interested in translating ideas into action.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248374 | PMC |
| http://dx.doi.org/10.1177/15598276221103470 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The impact of psoriatic arthritis on quality of life: a systematic review.
Ther Adv Musculoskelet Dis
December 2024
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, Windmill Road, Oxford OX3 7HE, UK.
Background: Psoriatic arthritis (PsA) is a chronic inflammatory condition that can affect individuals of all ages. Patients may experience a range of physical and psychological issues.
Objective: To examine the impact of PsA on an individual's quality of life (QoL) and physical function.
A Unique Phenotype of Maturity-Onset Diabetes of the Young With a Novel Disease-Causing Insulin Gene Variant.
JCEM Case Rep
January 2025
Department of Paediatric Endocrinology, Kandang Kerbau Women's and Children's Hospital, 229899 Singapore.
Maturity-onset diabetes of the young (MODY) represents 1% to 5% of patients with diabetes mellitus (DM), and numerous genes associated with MODY have been identified. While mutations of the insulin gene () are known to cause permanent neonatal DM, rare disease-causing variants have also been found in MODY. These patients demonstrate variable clinical phenotypes-from milder forms requiring lifestyle or oral agent interventions to severe forms requiring lifelong insulin.
View Article and Find Full Text PDFConjunctival ultraviolet autofluorescence as a biomarker of outdoor time in myopic children.
Front Med (Lausanne)
December 2024
Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.
Introduction: The prevalence of myopia has increased significantly in recent years including an earlier onset of myopia development on the pediatric population. The main objective of the study is to compare CUVAF (Conjunctival Ultraviolet Autofluorescence) in children with and without myopia to validate its usefulness as an outdoor protective biomarker.
Methods: A case-control observational study was conducted in a child cohort from subjects that attended to the Ophthalmology Department of Clínica Universidad de Navarra for an ophthalmological examination.
The fraction of cancer attributable to modifiable risk factors in Turkey in 2018.
Int J Cancer
December 2024
Faculty of Medicine, Department of Public Health, Division of Epidemiology, Dokuz Eylul University, Izmir, Turkey.
Cancer is the second leading cause of death in Turkey, with nearly one in six deaths attributed to the disease. In 2018, Turkey recorded 211,273 new cancer cases. Many cancers are linked to modifiable lifestyle risk factors, such as tobacco use, alcohol consumption, obesity, and inadequate diet and physical activity.
View Article and Find Full Text PDFJapan Diabetes Complications Study: Revisiting one of the first large-scale clinical studies in East Asians with diabetes.
J Diabetes Investig
December 2024
The Institute of Medical Science, Asahi Life Foundation, Tokyo, Japan.
This review highlights the significance of the Japan Diabetes Complications Study (JDCS), one of the earliest large-scale studies of people with type 2 diabetes outside Europe and the United States, in understanding type 2 diabetes mellitus among East Asian populations, particularly in Japan. Historically, large-scale clinical studies on type 2 diabetes mellitus have predominantly focused on Western populations, despite East Asians comprising the largest proportion of diabetic patients globally. The JDCS, which was initiated in 1996, enrolled 2,033 Japanese type 2 diabetes mellitus patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!